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Objective: Increasing experience with thoracic aortic stent grafts has led to a more aggressive approach to
thoracic aortic pathologies in the distal aortic arch and proximal descending thoracic aorta. To increase the length
of the proximal landing zone, it is sometimes necessary to cover the left subclavian artery with the thoracic stent-
graft, introducing the risk of retrograde filling of the excluded aorta from the left subclavian artery. It is currently
unclear how best to manage these patients to prevent persistent risk of aneurysm expansion or rupture. We report
our experience with a minimally invasive endovascular repair of the covered left subclavian artery.
Methods: We reviewed prospectively gathered data on all investigational device exemption-approved patients
undergoing thoracic aortic stent grafting at the Arizona Heart Institute from 2000 to 2006 (n ¼ 289 patients).
Patients had surveillance with a contrast-enhanced computed tomography scan on the first postoperative day
and during follow-up at 1, 6, and 12 months.
Results: A total of 289 patients received thoracic stent grafts during the study: Medtronic Talent (Medtronic,
Minneapolis, Minn) (n ¼ 25) or Gore TAG (WL Gore & Associates Inc, Flagstaff, Ariz) (n ¼ 261). The left
subclavian artery was covered in 23% of patients (n ¼ 66), of whom 17% had preoperative carotid-subclavian
bypass (n¼ 11/66). Among patients with left subclavian artery coverage, the 30-day mortality was 6.1% (n¼ 4),
procedure-related strokes developed in 3 patients (n ¼ 3, 4.6%), and the incidence of left arm claudication was
7.6% (n ¼ 5), necessitating postoperative carotid-subclavian bypass in 2 patients. Twelve patients (18%) had
a type I (n ¼ 6) or II (n ¼ 7) endoleak. Coverage of the left subclavian artery accounted for 71% of the type
II endoleaks (n ¼ 5), whereas patent intercostals accounted for the rest (n ¼ 2). Type II endoleaks associated
with left subclavian artery coverage were successfully treated by retrograde coil embolization from the left
brachial artery (n ¼ 3) or left subclavian artery ligation (n ¼ 1).
Conclusion: Coverage of the left subclavian artery during thoracic aortic stent grafting is associated with a low
incidence of arm complications and type II endoleaks. All type II endoleaks were successfully treated by retro-
grade coil embolization or ligation of the left subclavian artery. Successful treatment of endoleaks may reduce the
risk of aneurysm expansion or rupture.In 1994, Dake and colleagues1 published a landmark article
demonstrating the safe and effective treatment of thoracic
aortic aneurysms with endovascular stent-grafts. During
the last decade, endovascular techniques have been refined
and stent grafts have become commercially available, fuel-
ing an explosion of centers that offer endovascular stent
grafting to treat a wide range of thoracic aortic pathologies.
Although stent grafts were originally designed to treat aneu-
rysms of the descending thoracic aorta, the desire to avoid
the morbidity associated with traditional open repair has
broadened both the spectrum of thoracic diseases treated
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suitable for stent grafting.
Pathology adjacent to the left subclavian artery (LSA)
may necessitate stent graft coverage of the LSA origin to
adequately seal and fix the device at the proximal landing
zone. No consensus exists in the literature regarding whether
to simply cover the LSA or to revascularize the LSA before
stent graft deployment. Several studies have concluded that
the risks associated with simply covering the left subclavian
are low and reserve subclavian artery bypass only if
symptoms develop postoperatively in patients, such as left
arm claudication or vertebrobasilar insufficiency.2-10 Con-
versely, other centers report frequent complications related
to overstenting of the left subclavian and thus routinely
revascularize the LSA, with few exceptions.11-13
The sequelae of covering the LSA potentially include an
increased risk of left upper extremity ischemia, vertebroba-
silar insufficiency, stroke, and paraplegia. Retrograde filling
of the excluded aorta from a patent subclavian artery may
also predispose patients to a higher risk of type II endoleaks.
The purpose of this study is to determine the sequelae asso-
ciated with covering the LSA during thoracic aortic stentardiovascular Surgery c Volume 136, Number 5 1193
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grafting in a large series of patients, with particular emphasis
on the incidence of type II endoleaks related to a patent LSA.
We also report our experience with endovascular repair of
type II endoleaks associated with a covered LSA.
MATERIALS AND METHODS
We reviewed prospectively collected data on all patients receiving either
Gore TAG (WLGore&Associates Inc, Flagstaff, Ariz) orMedtronic Talent
(Medtronic, Minneapolis, Minn) thoracic endoprostheses at the Arizona
Heart Institute between 2000 and 2006. After institutional ethics review
board approval and informed consent were obtained, patients were prospec-
tively enrolled in a single-center investigational device protocol for either
the TAG or the Talent endoprosthesis. The study inclusion and exclusion
criteria, and the device characteristics have been described.14 Similar
inclusion criteria applied to patients receiving the Talent endoluminal graft,
except that a proximal and distal aortic neck length of at least 10 mm and
a diameter between 18 and 42 mm were considered acceptable.
We compared patients who received endoluminal grafts to the distal aor-
tic arch and the descending thoracic aorta (LSA covered, n ¼ 66), necessi-
tating coverage of the LSA, with patients who received endoluminal
grafting isolated to the descending thoracic aorta (conventional, n ¼ 223).
We excluded patients who underwent concomitant proximal aortic arch
endoluminal grafting and great artery transposition, and patients treated
with combined thoracic-infraceliac abdominal aortic endoluminal grafting
and abdominal visceral artery transposition.
Perioperative Management
All patients had preoperative contrast-enhanced computed tomography
(CT) and intraoperative aortography. In addition to aortography, we rou-
tinely examined the aorta from the ascending to the mid-abdominal aorta
with intravascular ultrasound (Volcano, Rancho Cordova, Calif) to confirm
preoperative CT measurements of the aortic diameter at the proximal and
distal landing zones. Intravascular ultrasound was particularly important
for identifying the true and false lumens when treating type B dissections.
We also screened most patients with duplex ultrasound to assess the patency
of the carotid and vertebral arteries. The presence of an atretic or stenotic
right vertebral artery is a potential risk factor for posterior circulation
strokes; therefore, we considered this a contraindication to unprotected
LSA overstenting. Patients treated on an urgent basis had intraoperative
arch aortograms to delineate the patency of the proximal vertebral arteries
and to identify potential anomalous vertebral artery origins (ie, arch
takeoff).
All procedures were performed by a cardiovascular or vascular surgeon
in a hybrid operating room equipped with a fixed, ceiling-mounted imag-
ing system. The details of our intraoperative management have been de-
scribed.14 Briefly, arterial access was obtained by exposing the common
femoral artery via a small oblique incision 2 to 3 cm above the groin
crease. If the common femoral or external iliac artery diameter was judged
insufficient to permit sheath insertion as determined by preoperative imag-
ing, a 10-mm Dacron graft was anastomosed directly to the common iliac
or distal abdominal aorta. After standard aortography and intravascular ul-
trasound examinations were completed, proximal and distal landing zones
were marked, the systolic blood pressure decreased to less than 100 mm
Hg, and the endoprosthesis was deployed over a double-curved, stiff
Lunderquist wire (LES3, Cook, Bloomington, Ind). The decision to cover1194 The Journal of Thoracic and Cardiovascular Sthe LSA was based on the diameter of the proximal thoracic aorta, the
length of normal aorta beyond the LSA origin, and the inner radius of
the aortic arch. If necessary to obtain adequate proximal fixation and
seal, while minimizing bird’s beaking, the LSA was covered. Early in
our series, a left carotid to subclavian bypass was performed before
planned coverage of the LSA; however, with increasing experience we
bypassed the LSA post-endoluminal grafting only in patients with symp-
toms of left upper extremity ischemia or vertebrobasilar insufficiency. We
considered a patent internal thoracic artery bypass graft and a functioning
arteriovenous fistula in the left upper extremity as absolute contraindica-
tions to LSA coverage.
Cerebrospinal fluid drains were not routinely used in either group but
were placed selectively in patients considered at high risk for paraplegia,
such as previous abdominal aortic aneurysm repair. Our postoperative pro-
tocol mandated strict blood pressure control to maintain a systolic blood
pressure greater than 140 mm Hg. If paraplegia or paraparesis developed
postoperatively, a spinal drain was placed and a high-dose dexamethasone
protocol was started.
Follow-up and Endoleak Management
Per the study protocols, patients had postoperative plain radiographs
(4 views) and noncontrast and contrast-enhanced CT scans at 1, 6, and 12
months, and then annually. If an endoleak was identified at 1 month, then
a repeat CT scan was performed at 3 months. Endoleaks were classified
according to standard nomenclature.15 Type II endoleaks were further
subdivided according to the causative branch vessel: LSA or intercostal.
Persistent type II endoleaks emanating from retrograde flow from the
LSA were confirmed by angiography performed percutaneously via a 6F
sheath placed in the left brachial artery. These endoleaks were treated by
depositing multiple platinum coils at the origin of the LSA, adjacent to
the stent graft.
Statistical Analysis
Statistical analysis was performed with SAS software (SAS version 8.1,
SAS Institute, Cary, NC). Continuous variables are expressed as mean 
standard deviation, and categoric variables are expressed as percentages
throughout the article. Comparisons of continuous variables between
groups were performed with unpaired Student t tests. Categoric variables
were analyzed with chi-square or Fisher’s exact tests. Backward stepwise
logistic regression identified independent predictors of death or paraplegia.
Survival between groups was compared by the Kaplan–Meier method.
RESULTS
The 2 groups of patients were comparable for all preoper-
ative characteristics with the exception that the LSA covered
group had a higher proportion of men and patients with a his-
tory of replacement of the ascending aorta (Table 1). Early in
our series, we performed left carotid-subclavian bypass (n¼
9/11) or LSA transposition (n¼ 2/11) before planned cover-
age of the LSA, resulting in a greater proportion of these
patients in the LSA covered group: Eight operations were
performed prophylactically, and 3 operations were per-
formed because of a specific contraindication to unprotected
LSA coverage (Table 1). The conventional group trended
toward a higher prevalence of patients with previous abdom-
inal aortic aneurysm repair and peripheral vascular disease
(Table 1).
The prevalence of thoracic aortic pathology varied be-
tween the 2 groups (Table 2, P<.001). Acute type B dissec-
tions and pseudoaneurysms were more prevalent in patientsurgery c November 2008
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ing contained ruptures, and penetrating atherosclerotic ul-
cers were more common in patients requiring stent grafts
isolated to the descending thoracic aorta (Table 2).
TABLE 1. Preoperative characteristics of patients treated with
thoracic endoluminal grafts: Left subclavian artery covered versus
isolated descending thoracic aorta (conventional)
Variable
LSA covered
(n ¼ 66)
Conventional
(n ¼ 223) P value
Age (y) 68  13 69  12 .3
Male sex 52 (79%) 122 (55%) .0004
Hypertension 53 (80%) 165 (74%) .3
Tobacco use 47 (71%) 162 (73%) .8
DM 4 (6.1%) 18 (8.1%) .6
CAD 23 (32%) 81 (35%) .6
Preoperative MI 9 (14%) 23 (10%) .4
Atrial fibrillation 8 (12%) 15 (6.7%) .15
CHF 5 (7.6%) 21 (9.4%) .6
PVD 3 (4.6%) 27 (12%) .08
Renal failure 6 (9.1%) 23 (10%) .8
Renal insufficiency 19 (29%) 55 (25%) .5
COPD 13 (20%) 51 (23%) .6
Preoperative CVA 5 (7.6%) 18 (8.1%) .9
Cancer history 7 (11%) 20 (9.0%) .7
Previous procedure
CABG 7 (11%) 20 (9.0%) .7
AAA repair 6 (9.1%) 40 (18%) .08
TAA repair 4 (6.1%) 10 (4.5%) .6
RAA 7 (11%) 7 (3.1%) .02
Preoperative carotid
to LSA bypass
11 (17%) 2 (0.9%) <.0001
DM, Diabetes mellitus; CAD, coronary artery disease; MI, myocardial infarction;
CHF, congestive heart failure; PVD, peripheral vascular disease; COPD, chronic ob-
structive pulmonary disease; CVA, cerebrovascular accident; CABG, coronary artery
bypass grafting; AAA, aortic abdominal aneurysm; TAA, thoracic aortic aneurysm;
RAA, replacement ascending aorta; LSA, left subclavian artery.
TABLE 2. Etiology of thoracic aortic disease: Left subclavian artery
covered versus isolated descending thoracic aortic (conventional)
stenting
Etiology
LSA covered
(n ¼ 66)
Conventional
(n ¼ 223)
Aneurysm 20 (30%) 97 (44%)
Type B dissection
Acute 19 (29%) 26 (12%)
Chronic 10 (15%) 33 (15%)
Penetrating ulcer 2 (3.0%) 28 (13%)
Contained rupture 1 (1.5%) 15 (6.7%)
Pseudoaneurysm 8 (12%) 8 (3.6%)
Traumatic transection 2 (3.0%) 8 (3.6%)
Aortobronchial fistula 2 (3.0%) 5 (2.2%)
Atheroembolic aorta 0 2 (0.9%)
Coarctation repair 0 1 (0.5%)
Endoleak repair 2 (3.0%) 0
LSA, Left subclavian artery.The Journal of Thoracic and CTable 3 summarizes the procedural characteristics for
both groups. The majority of patients in both groups were
treated with a Gore TAG endoprosthesis, with a few patients
receiving Medtronic Talent devices. The intraoperative vari-
ables were similar for both groups; however, careful posi-
tioning of a stent graft distal to the left common carotid
artery during planned coverage of the LSA required a greater
volume of contrast compared with isolated descending tho-
racic aortic stenting (Table 3).
The 2 groups were similar for all postoperative outcome
variables, except patients who had the LSA covered during
stent grafting had a higher incidence of left upper extremity
claudication (Table 4, 7.6% vs 0.5% for LSA covered vs
conventional, respectively, P ¼ .003) Symptoms related to
subclavian artery coverage were generally mild and con-
sisted of left upper extremity fatigue with exercise, coolness,
and episodic paresthesias. Two patients (2/66, 3%) experi-
enced symptoms severe enough to warrant postoperative
subclavian revascularization: One patient had severe
TABLE 3. Procedural characteristics during thoracic endoluminal
grafting: Left subclavian artery covered versus isolated descending
thoracic aortic (conventional) stenting
Variable
LSA covered
(n ¼ 66)
Conventional
(n ¼ 223) P Value
Estimated blood loss (mL) 378  301 403  474 .7
Contrast (mL) 379  171 323  172 .02
No. of grafts/patient 1.5  0.75 1.5  0.98 .9
Type of device .6
Gore TAG
(WL Gore & Associates
Inc, Flagstaff, Ariz)
62 (94%) 199 (89%)
Medtronic Talent (Medtronic,
Minneapolis, Minn)
4 (6%) 21 (9.4%)
Both 0 3 (1.4%)
Retroperitoneal conduit 4 (6.1%) 28 (13%) .14
LSA, Left subclavian artery.
TABLE 4. Postoperative outcomes after thoracic endoluminal
grafting: Left subclavian artery covered versus isolated descending
thoracic aortic (conventional) stenting
Outcome
LSA covered
(n ¼ 66)
Conventional
(n ¼ 223) P value
Perioperative MI 3 (4.6%) 5 (2.2%) .3
Respiratory failure 0 5 (2.2%) .6
Renal failure 3 (4.6%) 12 (5.4%) 1.0
Stroke/TIA 3 (4.6%) 8 (3.6%) .7
Paraplegia/paraparesis 2 (3.0%) 10 (4.5%) 1.0
Access complications .2
Iliac rupture 0 3 (1.4%)
Iliac stent 0 10 (4.5%)
Left upper extremity
claudication
5 (7.6%) 1 (0.5%) .003
Length of stay 4.8  4.9 5.0  4.9 .8
Mortality, 30 d 4 (6.1%) 10 (4.5%) .5
MI, Myocardial infarction; TIA, transient ischemic attack.ardiovascular Surgery c Volume 136, Number 5 1195
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been related to a synchronous left brachial thrombus; never-
theless, the patient underwent simultaneous brachial embo-
lectomy and LSA transposition. One patient experienced
left arm claudication in conjunction with intermittent dizzi-
ness necessitating carotid-subclavian bypass 3 weeks after
the initial procedure.
The incidence of neurologic complications was similar in
both groups (Table 4). There were no cases of paraplegia in
the group with the LSA covered; however, 2 patients expe-
rienced paraparesis: One patient had mild bilateral lower ex-
tremity weakness after placement of 2 stent grafts for
a ruptured type B dissection, and 1 patient experienced iso-
lated, mild right lower extremity weakness that completely
resolved by 6 months. Three patients (4.6%) in the LSA
covered group experienced perioperative strokes: 1 left tem-
poroparietal stroke, 1 parieto-occipital stroke, and 1 undeter-
mined territory (the patient died of a new stroke after transfer
to an outside facility).
Twelve patients (18%) who had the LSA covered devel-
oped a type I (n¼ 6/66) or II (n¼ 7/66) endoleak diagnosed
immediately after stent grafting or during follow-up (1
patient had both type I and II endoleaks). Table 5 summa-
rizes the type II endoleaks according to the branch vessel
supplying the endoleak. Retrograde flow from a covered
LSA accounted for 71% of the type II endoleaks (n ¼ 5),
whereas patent intercostals accounted for the rest (n ¼ 2).
Type II endoleaks associated with left subclavian coverage
were successfully treated by either retrograde coil emboliza-
tion from the left brachial artery (n¼ 3, Figure 1) or left sub-
clavian ligation in conjunction with carotid-subclavian
bypass (n ¼ 1). One patient had a small type II endoleak
from a patent LSA diagnosed at 1 month postoperatively;
however, the 6-month CT scan demonstrated complete res-
olution of the endoleak. Two patients with type II endoleaks
emanating from patent intercostals were managed conserva-
tively: The endoleak resolved in 1 patient by 6 months, and
the other patient was lost to follow-up.
The 30-day mortality was similar between the 2 groups
(Table 4, 6.1% vs 4.5% for LSA covered vs conventional1196 The Journal of Thoracic and Cardiovascular Sugroup, respectively, P ¼ .5). The 5-year mortality was
equivalent between groups (Figure 2, 68.3% vs 69.4% for
LSA covered vs conventional group, respectively, P ¼ .5).
DISCUSSION
In this study, we reviewed our large series of patients who
had the LSA covered during endovascular stent graft repair
for thoracic aortic pathology and compared the results with
those of patients undergoing stent grafting isolated to the de-
scending thoracic aorta.We demonstrate that overstenting of
the LSA is associated with a relatively low incidence of left
upper extremity complications, a low stroke and paraplegia
rate comparable to patients who did not have left subclavian
overstenting, and a low incidence of type II endoleaks.
To adequately fix thoracic stent grafts in the prox-
imal landing zone, high-volume thoracic endografting cen-
ters cover the LSA in 12% to 34% of all thoracic
cases.2,4,6,14,16-18 We covered the LSA in 23% of patients
(n ¼ 66/289) who underwent thoracic endografting for
a wide range of thoracic aortic pathologies, confirming
that LSA coverage is necessary in a large number of patients.
Despite the frequent need to cover the LSA during thoracic
stent grafting, no uniform consensus exists regarding
whether to selectively or routinely revascularize the LSA.
Early in our experience, we electively revascularized the
first 8 patients (12%) scheduled for planned coverage of
the LSA, but our management evolved over the study period
to revascularize patients only if they had a specific contrain-
dication to unprotected overstenting (3 patients), namely,
a patent left internal thoracic to left anterior artery descend-
ing artery bypass, a functioning left upper extremity arterio-
venous fistula, or stenosis of the vertebral arteries. Thus, the
majority of patients (83%, n ¼ 55/66) who had LSA over-
stenting did not have preoperative revascularization, yet
only 5 patients (9%, n ¼ 5/55) developed left arm claudica-
tion and only 2 patients required postoperative LSA revascu-
larization to relieve left arm claudication or paresthesias. No
patient developed critical limb ischemia or rest pain. The
extensive collateral blood supply to the left subclavian and
axillary arteries may explain the low incidence of acuteTABLE 5. Treatment of type II endoleaks associated with coverage of the left subclavian artery (n ¼ 66)
Type II endoleak Patient Time from procedure Reintervention Follow-up
Retrograde from LSA (n ¼ 5/66)
1 POD 2 Coiled from L brachial Sealed
2 1 y Ligation LSA and L carotid-subclavian
bypass
Sealed
3 OR Coiled from L brachial Sealed
4 1 mo No Sealed
5 6 mo Coiled from L brachial Sealed
Intercostal artery (n ¼ 2/66)
5 1 mo No Lost to follow-up
6 1 mo No Sealed
LSA, Left subclavian artery; POD, postoperative day; L, left; OR, operating room.rgery c November 2008
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(arrow). Sagittal (B) and 3-dimensional 64-slice CT reconstructions (C) after multiple platinum coils (arrow) were placed at the origin of the LSA, adjacent to
the endograft, with seal of the endoleak (thrombus depicted by arrow).ischemia observed after coverage of the left subclavian ori-
gin: most studies report a 0% incidence of acute left upper
extremity ischemia;3-8,10,17 however, a few cases of critical
ischemia13 or rest pain2 have been described. The reported
incidence of left upper extremity symptoms, such as claudi-
cation, weakness, coolness, or paresthesias, attributable to
LSA coverage, is more variable and ranges from 0% to
35%.2-7,10
Coverage of the LSA may also increase the risk of poste-
rior circulation strokes, particularly if the right vertebral ar-
tery is absent or stenotic. In the present series, the incidence
of stroke was comparable between the 2 groups (4.6% vs
FIGURE 2. Long-term survival for the LSA covered versus the conven-
tional group by the Kaplan–Meier method. LSA, Left subclavian artery.The Journal of Thoracic and C3.6% for LSA covered and conventional, respectively).
Only 1 patient in whom the LSA was covered had a con-
firmed posterior circulation stroke, suggesting that the ma-
jority of strokes in both groups were atheroembolic,
induced by manipulating guidewires, catheters, and devices
in the transverse arch. The incidence of stroke reported by
institutions with considerable experience with left subcla-
vian overstenting ranges from 0%4,17 to 1.6%6 to as high
as 10.7%;2 the majority of the strokes observed in these
studies were also attributed to atheroemboli based on the pat-
tern and distribution of lesions observed on postoperative
head CT scans.2,6 A recent study of 153 patients who under-
went thoracic stent grafting identified peripheral vascular
embolization as a predictor of stroke, further supporting
the concept that atheroemboli is the major source of strokes
during stent grafting.19 The LSA was covered in 39 patients
(25%) in this study and was not identified as a predictor of
stroke.
In contrast, several other studies suggest an association
between left subclavian overstenting and posterior circula-
tion strokes.7,12,16 Peterson and colleagues12 noted 4 postop-
erative strokes in 8 patients who had left subclavian
overstenting without previous revascularization; 1 patient
had a left middle cerebral territory stroke, and 3 patients
had posterior circulation strokes. Although 1 of the patients
with a posterior circulation stroke also had small diffuse
strokes in both anterior cerebral distributions, suggestive
of atheroembolic strokes, 2 of these patients had left-sided
posterior strokes and review of the preoperative imaging re-
vealed that the right vertebral was absent in both cases.ardiovascular Surgery c Volume 136, Number 5 1197
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circle of Willis does not necessarily predict the patients
who are at risk for developing posterior circulation strokes.
Song and colleagues7 observed 3 of 42 posterior circulation
strokes after thoracic endografting (2/11 in patients with left
subclavian overstenting), despite a normal intracerebral
circulation as defined by preintervention magnetic reso-
nance angiography.
Although our data confirm that the incidence of posterior
circulation strokes is likely low, a careful and thorough pre-
operative evaluation is warranted to minimize the stroke risk
and guide the decision to revascularize the LSA before over-
stenting. We routinely evaluate the carotid and vertebral
arteries before planned LSA coverage with duplex ultra-
sound. In emergency cases, such as traumatic disruption or
contained rupture, we attempt to visualize the vertebral
arteries with intraoperative angiography. A hemodynami-
cally significant stenosis or an absent right vertebral artery
would prompt preintervention revascularization of the
LSA. Early in our series, we did not routinely assess the
anatomy of the intracerebral circulation; however, we have
started evaluating the cerebrovascular circulation with re-
constructed 64-slice CT scans (Figure 3). Although the rela-
tionship between an incomplete circle of Willis and the risk
of posterior circulation stroke during LSA overstenting is
unclear at present, a cautious approach would be to revascu-
larize the LSA before overstenting if an incomplete circle of
Willis was documented on preoperative imaging.
Spinal cord ischemia and paraplegia are complications
after thoracic stent-graft repair. Most large series report an
incidence of paraplegia/paraparesis between 2% and 4%
(range 0%–6.7%).6,14,16,18-23 Coverage of the hypogastric
arteries,19 previous or concomitant abdominal aortic aneu-
rysm repair,24 or extensive coverage of the aorta25 may com-
promise collateral blood flow to the spinal cord and have all
been cited as risk factors for spinal cord ischemia. The LSA
also supplies collateral blood flow to the spinal cord via the
vertebral and anterior spinal arteries, yet coverage of the
origin of the LSA does not seem to increase the risk of para-
plegia/paraparesis.2,5-7,19,23 In the present series, the risk of
spinal cord ischemia was similar in the 2 groups (3% vs
4.5% for LSA covered and conventional, respectively), de-
spite a 9.1% and an 18% prevalence of previous abdominal
aortic aneurysm repair in the LSA covered and the conven-
tional groups, respectively.
Covering the origin of the LSA without previous ligation
or transposition has the added potential to fill the excluded
aorta retrogradely, resulting in a type II endoleak. The natu-
ral history of type II endoleaks after thoracic endografting
was initially considered benign; however, several recent
reports indicate continued aneurysm sac expansion in the
presence of a type II endoleak.26,27 We observed type II en-
doleaks secondary to retrograde filling via the LSA in 7.6%
of patients (5/66). The endoleak resolved spontaneously in 11198 The Journal of Thoracic and Cardiovascular Spatient; however, 4 patients required coil embolization of the
origin of the left subclavian (n¼ 3) or ligation of the prever-
tebral segment (n ¼ 1) to seal the endoleak. Unless the pa-
tient has symptoms indicating a need to revascularize the
LSA, we prefer coiling the origin of the left subclavian be-
cause it is relatively easy to perform percutaneously via
the left brachial artery and well tolerated by the patient,
and we have had good success sealing these endoleaks.
The incidence of type II endoleaks resulting from patent in-
tercostal arteries was low (2/66, 3%), similar to the rate re-
ported in the literature.16,20,28 We managed these patients
conservatively because type II endoleaks emanating from
patent intercostals are thought to pose a low risk for aortic
rupture and eventually seal spontaneously.
CONCLUSIONS
In the majority of patients requiring endovascular repair
for a broad range of thoracic aortic pathologies, coverage
of the LSA without previous or concomitant revasculariza-
tion is well tolerated, provided they have no contraindication
FIGURE 3. Preoperative assessment of normal cerebrovascular anatomy
in a patient scheduled for thoracic endografting with planned LSA coverage
(3-dimensional reconstructions based on a 64-slice CT scan).urgery c November 2008
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of critical left upper extremity ischemia is negligible, post-
operative left subclavian revascularization can be performed
electively for the small percentage of patients in whom per-
sistent and intolerable arm claudication or vertebrobasilar
insufficiency develops. Although the incidence of stroke
and paraplegia is low and comparable in patients receiving
thoracic stent grafts, regardless of left subclavian overstent-
ing, a thorough preoperative evaluation to define the cere-
brovascular circulation is warranted to define the subgroup
of patients at high risk for posterior circulation strokes
who may benefit from preprocedural left subclavian revas-
cularization. Retrograde coil embolization of the LSA origin
via the ipsilateral brachial artery is a simple and effective
method to treat type II endoleaks.
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